Margaret A. Hamburg's most recent trade in Alnylam Pharmaceuticals Inc was a trade of 1,558 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 1,558 | 1,558 | - | - | Stock Option (right to buy) | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 775 | 911 (0%) | 0% | 0 | Common Stock | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 5,228 | 5,228 | - | - | Stock Option (right to buy) | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 3,454 | 3,454 | - | - | Stock Option (right to buy) | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 136 | 0 | - | - | Restricted Stock Units | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 136 | 136 (0%) | 0% | 0 | Common Stock | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 5,153 | 5,153 | - | - | Stock Option (right to buy) | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 136 | 136 | - | - | Restricted Stock Units | |
Alnylam Pharmaceuticals Inc | Margaret A. Hamburg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 4,032 | 4,032 | - | - | Stock Option (right to buy) |